|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1825 I STREET NW |
Address2 | SUITE 401 |
| City | WASHINGTON |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 18353-12
|
||||||||
|
6. House ID# 363510000
|
||||||||
| TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Tricia Guay |
Date | 1/20/2023 2:49:30 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Advantage (Part C) and Prescription Drug (Part D) programs including: quality measures and star ratings; quality bonus payments; third-party marketing tactics; prescription drug costs; benchmark reform; and program integrity audits.
Advocated for extending all COVID-19 related telehealth Medicare regulatory flexibilities for two years post-public health emergency (H.R. 4040).
Advocated in support of extending the Acute Hospital Care at Home waiver to allow seniors to receive inpatient-level care at home beyond the public health emergency, including support for the "Hospital Inpatient Services Modernization Act (S. 3792/H.R. 7053).
Advocated in support of improving Medicaid access and coverage, including 12-month coverage for post-partum and continuous eligibility for children in CHIP and Medicaid; advocated to strengthen and expand home- and community-based services (HCBS).
Prior Authorization: Advocated for any legislation/regulation addressing electronic prior authorization to improve consumers access to appropriate care in a timely fashion, reduce instance of inappropriate or low-value care and create a standard for electronic prior authorization across all lines of business; Advocated for ensuring that health plans and providers share equally in the development and implementation of electronic prior authorization requirements.
Advocated in favor of addressing Social Determinants of Health (SDOH), including maternal health and health equity, across Medicaid and Medicare.
Advocated for Medicaid redeterminations to be conducted in chronological order, with added safeguards for mothers and children to ensure continuity of coverage; advocated for increased time granted to states to conduct redeterminations and ample lead time for plans to help assist enrollment efforts; advocated for increased flexibilities, including texting, to plans to conduct outreach for enrollees at risk of losing coverage during the redetermination process; advocated for additional time granted to plans to help transition Medicaid enrollees to other forms of coverage; advocated for phasing out of the enhanced FMAP upon the end of the PHE to help states with funding and staffing support as they conduct redeterminations.
Advocated for reimbursement of food security interventions (e.g., Food Farmacies, Medically Tailored Meals) in publicly sponsored programs.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tricia |
Barrentine Guay |
|
|
|
Matthew |
Dobias |
|
|
|
Michael |
Bagel |
|
|
|
Dan |
Jones |
|
|
|
Virginia |
Whitman |
|
|
|
Michael |
Angeloni |
|
|
|
Nissa |
Shaffi |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Advocated for health care affordability measures, including continuous coverage for children in state Childrens Health Insurance Plans (CHIP) and 12-month post-partum coverage for pregnant women.
Advocated for making COVID-19 related telehealth regulatory flexibilities permanent.
Advocated for repeal of the in-person requirement for tele-mental health visits (H.R. 4058/S. 2061))
Mental and Behavioral Health: advocated in support of integration, collaborative care and access to mental and behavioral health services; advocated for mental health parity and greater access to mental and behavioral health services overall.
Advocated for reimbursement of food security interventions (e.g., Food Farmacies, Medically Tailored Meals) in publicly sponsored programs.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tricia |
Barrentine Guay |
|
|
|
Michael |
Bagel |
|
|
|
Matthew |
Dobias |
|
|
|
Dan |
Jones |
|
|
|
Virginia |
Whitman |
|
|
|
Michael |
Angeloni |
|
|
|
Nissa |
Shaffi |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |